Bill > SB0065

This bill amends Utah's licensing regulations for residential treatment programs and recovery residences to address medication-assisted treatment (MAT), which involves using FDA-approved medications like buprenorphine, methadone, or naltrexone to treat substance use disorders. Specifically, the bill prohibits qualified residential treatment programs and recovery residences from refusing to accept clients solely based on their use of medication-assisted treatment when recommended by a licensed prescriber. The bill requires these facilities to allow clients to receive medication-assisted treatment as recommended by a licensed healthcare provider and mandates that Medicaid provider contracts include provisions obligating compliance with these requirements. Additionally, the bill updates various definitions in the state code, including adding a new definition for "medication assisted treatment" and making technical changes to section numbering and cross-references. The changes are aimed at ensuring that individuals seeking treatment for substance use disorders can access comprehensive care that may include medication-assisted treatment without discrimination. The bill is set to take effect on May 7, 2025.

Health and Social Services

https://le.utah.gov/~2025/bills/static/SB0065.html